Women Powering the Longevity Revolution
From gene therapy to AI-powered diagnostics, a new wave of female innovators is leading the charge in the longevity field. Meet the women redefining aging.
Aging isn’t what it used to be. It’s no longer just about adding years to life but ensuring those years are vibrant, and energetic. At the forefront of this transformation are remarkable women whose latest ventures and achievements are pushing the boundaries of what’s possible in longevity science.
From AI-powered diagnostics to gene therapy breakthroughs, these women are proving that the future of aging is not just about science, it’s about redefining what it means to thrive at every stage of life.
Meet the Women Shaping the Future of Longevity
Joanna Bensz
CEO, Longevity Center
Joanna Bensz is redefining healthcare by integrating advanced diagnostics and epigenetics into Longevity Centers across Europe, showcasing how precise healthcare can enhance both lifespan and healthspan.
Joanna's vision combines advanced diagnostics with holistic health strategies, empowering people to take charge of their health, detect issues early, and optimize their well-being for the long run. Her commitment to international collaboration is driving global progress in aging research, shaping the future of longevity.
Latest News & Milestones:
The Longevity Center, expanded to Zurich, opening a state-of-the-art center with continuous biomarker monitoring, diagnostics, and personalized health programs.
Launched the Brain & Memory Lab in collaboration with neurologist Dr. Stanisław Szlufik, pioneering cognitive-function optimization protocols for prevention and neurodegenerative conditions management
Hosted the Buck Institute Clinics Roundtable, setting global standards in longevity for longevity clinics.
Celine Halioua
Founder & CEO, Loyal
Celine is pioneering longevity drugs for dogs! Through Loyal, she’s developing FDA-approved longevity drugs for dogs, that could eventually translate to humans.
By extending healthy lifespan in dogs, Celine’s work helps fast-track discoveries that could one day slow aging in humans! Her research isn’t just about dogs; it’s paving the way for science-backed longevity solutions that could directly impact our own well-being.
Latest News & Milestones:
Loyal’s drug candidate LOY-002 cleared a major FDA milestone, becoming the second approved longevity therapy for dogs!, bringing canine longevity closer to market.
Loyal Launched STAY study, enrolling 1,000 senior dogs to evaluate the impact of LOY-002 on healthy lifespan.
Elizabeth Parrish
CEO, BioViva
Liz isn’t just advocating longevity; she's living proof. As the first person to undergo experimental gene therapy aimed at cellular rejuvenation, she’s testing the limits of regenerative medicine at BioViva.
Her fearless approach to self-experimentation and advocacy for genetic solutions is accelerating breakthroughs that could one day help us stay healthier for longer.
Latest News & Milestones:
Elizabeth Parrish, CEO of BioViva, will be speaking at the Longevity Summit Dublin 2025
Early trials of BioViva’s telomerase + Klotho gene therapies showed promising cognitive improvements in dementia patients.
Their CMV vector increased mouse lifespans by 41.4%, sparking hope for future therapies against Alzheimer’s and muscle loss.
BioViva successfully raised Series A funding, showing wider acceptance to advance gene-therapy research.
Kayla Barnes
CEO, LYV Wellness & Co-Founder, The Health Optimization Fund
Kayla Barnes is proof that longevity isn’t just a science, it’s a lifestyle. As the owner of LYV Wellness, and a Female Longevity Community, Kayla empowers women, through practical, data-driven longevity programs. She also hosts the Longevity Optimization Podcast, where she shares actionable insights and expert discussions.
Kayla makes longevity accessible and achievable. With a focus on women's health and longevity optimization, she translates complex science into actionable strategies.
Latest News & Milestones:
LYV Wellness introduced advanced clinical programs, including multi-omics profiling and exosome injections aimed at reducing cellular senescence and optimizing real-time protocols.
She published a comprehensive female longevity data set and created a Female Longevity Membership, reaching over 300,000 women worldwide.
Started the Longevity Optimization Podcast, featuring discussions with top experts from around the world.
Dr. Amy B. Killen
Longevity & Regenerative Medicine Physician, Co-founder at Humanaut Health
Amy is revolutionizing regenerative medicine, specializing in longevity-based aesthetics, sexual health, and hormone optimization. She’s known for her work in stem cell therapies and platelet-rich plasma (PRP) treatments.
She bridges the gap between cutting-edge regenerative therapies and everyday well-being, proving that true longevity is about thriving with energy, vitality, and confidence.
Latest News & Milestones:
Humanaut Health raised $8.7 million in seed funding to expand personalized longevity clinics, making high-end regenerative therapies more accessible.
Amy launched the Human Optimization Project (HOP) Box, a doctor-formulated supplement kit designed to enhance women’s longevity.
She is speaking at the Longevity Docs Hormones & Longevity Mastermind event in New York City on March 29th, 2025
Nikolina Lauc
CEO, GlycanAge
Nikolina is at the forefront of glycobiology, pioneering ways to measure biological age through glycan-based biomarkers. Her company, GlycanAge, provides personalized health insights through simple at-home testing.
Nikolina Lauc turns lab research into practical tools, helping you measure and improve your biological age with real data, so you can take control of your health and aging journey.
Latest News & Milestones:
GlycanAge raised $4.2 million in seed funding, accelerating global expansion of its glycan-based diagnostic platform.
In 2023, Nikolina, was recognized as the Entrepreneur of the Year in Croatia
Dr. Casey Means
Co-Founder, Levels
Casey is a pioneer in metabolic health and co-founder of Levels, a platform that uses real-time glucose monitoring and AI-driven insights to empower healthier lives.
Dr. Casey helps you understand how stable blood sugar and balanced energy aren’t just health trends, they’re the foundation for a longer, healthier life. Her work shows that optimizing your metabolism can sharpen your mind, boost daily energy, and reduce long-term disease risk.
Latest News & Milestones:
Levels secured a $10 million Series A, including $3 million in crowdfunding from over 2,000 investors to democratize glucose monitoring.
Dr. Casey Means co-authored the #1 New York Times bestseller "Good Energy: The Surprising Connection between Metabolism and Limitless Health," which has been on the bestseller list for months
Dr. Andrea Maier
Co-Founder, Chi Longevity & Professor, NUS
Andrea blends research and practice, helping people adopt scientifically proven interventions for healthier aging through her Chi Longevity clinics.
She is a leading force in aging research, making longevity science accessible and cutting through the hype with evidence-based solutions. She champions personalized interventions based on your unique biomarkers, shifting the focus from generic supplements to targeted strategies that truly impact health and longevity.
Latest News & Milestones:
Chi Longevity opened its second clinic at the Four Seasons Hotel Singapore, expanding its presence in Asia and marking a shift toward luxury, data-driven longevity treatments geared toward individuals seeking precision health solutions.
She Co-hosted the Founders Longevity Forum addressing APAC’s aging challenges and reinforcing Singapore’s leadership in geroscience.
Dr. Evelyne Bischof
Physician-Scientist, President at Healthy Longevity Medicine Society
Evelyne is championing AI-driven longevity medicine, setting standards for predictive diagnostics and precision longevity therapies worldwide. She also directs the Longevity Department at the renowned Sheba Medical Center in Israel, integrating geroscience into hospital practice.
Her work is unique. It’s not just about one discovery. It’s about building an entire ecosystem: educating doctors, setting clinical guidelines, and ensuring that longevity breakthroughs actually reach patients.
Latest News & Milestones:
Dr. Evelyne was appointed President of the Healthy Longevity Medicine Society (HLMS), she launched a global initiative to standardize AI-powered biomarkers and clinical protocols for longevity.
She played a significant role in the 2024 Longevity Investors Conference in Davos, Switzerland, participating in multiple panels on topics such as "Latest Developments in Longevity and AI" and "A Roadmap to Sustainable Health and Better Wellbeing in the Workforce and Society"
Continues her role as Medical Director of the Sheba Longevity Center at Sheba Medical Center, affiliated with Tel Aviv University, while also serving as a professor at Shanghai University of Medicine and Health Sciences
Nabiha Saklayen
Co-Founder, Cellino
Nabiha Saklayen is using laser-based technology to revolutionize stem cell therapies, making regenerative medicine more precise and scalable.
Her work is paving the way for affordable, accessible regenerative medicine, bringing cutting-edge cell therapies closer to those who need them. This could mean a future where treating chronic diseases is faster, more effective, and within reach for more people.
Latest News & Milestones:
Cellino just announced a partnership with Matricelf to scale iPSC-based spinal cord injury therapies.
Cellino launched The Foundry; the first AI-powered hospital-based iPSC manufacturing facility. Advancing their goal of making patient-specific stem cell-derived therapies available for broad patient audiences
Cellino was awarded $25M in funding from the ARPA-H, to drive the development of their biomanufacturing technology for personalized regenerative medicine.
Anastasia Georgievskaya
CEO, Haut.AI
Anastasia Georgievskaya is transforming skincare with AI-driven solutions that personalize beauty and longevity interventions, making cutting-edge technology accessible.
Her AI-driven approach to skincare helps you understand your skin’s unique needs, using data to predict and prevent aging signs before they appear. By combining science and technology, she’s making smarter skincare choices effortless.
Latest News & Milestones:
Haut.AI’s commercially launched SkinGPT, generative AI platform that simulates the effects of skincare products and treatments, revolutionizing virtual skincare try-ons for beauty brands.
They introduced "Generative Skin: Library of Ingredient Effects," an interactive website allowing users to visualize the impact of various skincare ingredients on their skin through AI-generated simulations
Haut.AI was granted a United States patent for its Skin Atlas system, which provides detailed skin analysis and personalized skincare recommendations while ensuring user privacy through advanced anonymization techniques
Carolina Reis & Alessandra Zonari
Co-Founders, OneSkin
This duo is redefining skincare by targeting the root causes of aging at the cellular level through pioneering longevity-focused topical treatments.
They’re proving that longevity science isn’t just for the future—it’s for your skin today. By using peptide technology to slow cellular aging, they help you maintain healthier, more resilient skin for the long run.
Latest News & Milestones:
Their patented Peptide OS-01 has been scientifically proven to reverse skin's biological age by preventing the accumulation of senescent cells, positioning OneSkin as a leader in science-led topical skin longevity treatments
OneSkin secured a $20 million Series A funding round, with Unilever Ventures among its key investors, signaling potential industry collaborations.
OneSkin was recognized by Fast Company as one of 2024’s Most Innovative Companies, OneSkin is expanding its product line to further integrate molecular-level skin health solutions.
Dr. Elisabeth Roider
Partner & CSO, Maximon
Dr. Elisabeth Roider is a physician-scientist specializing in longevity biotech. She is the Chief Scientific and Medical Officer at Maximon AG, where she helps startups develop innovative solutions for healthy aging. She also works at University Hospital Basel and Harvard Medical School, contributing to advanced research in aging and regenerative medicine.
Her work bridges science and innovation, bringing breakthroughs breakthroughs in longevity into real-world solutions that may slow aging and improve quality of life.
Latest News & Milestones:
Ayun Longevity Clinic launched in Zürich under Elisabeth’s leadership, offering advanced diagnostics and personalized treatments.
She oversaw the launch of a CHF 100 million Longevity Co-Investment Fund, supporting startups focused on aging interventions and longevity biotech.
She joined Maximon's leadership team as Partner and Chief Scientific and Medical Officer in 2022, bringing her expertise as a Harvard- and Swiss-trained physician-scientist to drive innovation in the longevity field
Dr. Alexandra Bause
Co-Founder & Partner, Apollo Health Ventures
Alexandra is shaping the future of longevity biotech as a Co-Founder and Partner at Apollo Health Ventures, a leading venture capital firm funding cutting-edge companies developing therapies to extend human healthspan.
Her vision ensures that longevity research transitions from the lab to transformative therapies. She focuses on high-impact investments and supports biotech startups from early-stage research to commercialization.
Latest News & Milestones:
Apollo Health Ventures' portfolio company, Auron Therapeutics, Inc., recently received FDA approval for their investigational drug AUTX-703 and raised $27M in Series B funding to initiate Phase 1 trials in hematologic malignancies.
Refoxy Pharma, successfully raised €9.1M in a seed-extension financing round to accelerate the preclinical development of novel FOXO3 activators targeting idiopathic pulmonary fibrosis
Apollo-backed Ochre Bio secured a $1 billion deal with Boehringer Ingelheim for AI-driven liver disease therapeutics.
These women are not only shaping the future of longevity, they’re making it personal. Their work is turning aging into an opportunity to thrive.
As we follow their journeys, one thing is clear: the longevity revolution is powered by passion, innovation, and a belief that every stage of life can be lived to its fullest.